Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma
Clinical trial NCT00856245 · COMPLETED
Trial details
- NCT number
- NCT00856245
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2015-07-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.